Inflammatory signaling compromises cell responses to interferon alpha
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory signaling compromises cell responses to interferon alpha
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 2, Pages 161-172
Publisher
Springer Nature
Online
2011-06-13
DOI
10.1038/onc.2011.221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-killing of melanoma cells by cytosolic delivery of dsRNA: Wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells
- (2010) Direna Alonso-Curbelo et al. Autophagy
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study
- (2010) Rosalynn M. Nazarian et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
- (2010) S. Mocellin et al. JNCI-Journal of the National Cancer Institute
- Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
- (2010) H. Zheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Melanoma cell-secreted soluble factor that stimulates ubiquitination and degradation of the interferon alpha receptor and attenuates its signaling
- (2010) Wei-Chun HuangFu et al. Pigment Cell & Melanoma Research
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy
- (2009) K. S.M. Smalley et al. CANCER RESEARCH
- Pegylated interferons: Prospects for the use in the adjuvant and palliative therapy of metastatic melanoma
- (2009) Katharina C. Kaehler et al. EUROPEAN JOURNAL OF CANCER
- Redefining the role of interferon in the treatment of malignant diseases
- (2009) Sergio Bracarda et al. EUROPEAN JOURNAL OF CANCER
- Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor
- (2009) Sabyasachi Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
- (2009) Miyako Okamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mammalian Casein Kinase 1 and Its Leishmanial Ortholog Regulate Stability of IFNAR1 and Type I Interferon Signaling
- (2009) J. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Inflammation and melanoma metastasis
- (2009) Vladislava O. Melnikova et al. Pigment Cell & Melanoma Research
- Multidisciplinary Treatment of Primary Melanoma
- (2009) Katharine Yao et al. SURGICAL CLINICS OF NORTH AMERICA
- Ligand-independent pathway that controls stability of interferon alpha receptor
- (2008) Jianghuai Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- Reproducibility of serum cytokines and growth factors
- (2008) Yian Gu et al. CYTOKINE
- Cutaneous head and neck melanoma: the old and the new
- (2008) Nestor R Rigual et al. Expert Review of Anticancer Therapy
- Adjuvant therapy of melanoma with interferon: lessons of the past decade
- (2008) Paolo A Ascierto et al. Journal of Translational Medicine
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases
- (2008) Faina Linkov et al. Proteomics Clinical Applications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started